Lower periorbital area treatment with Restylane Vital Skinbooster
Abstract
Facial aging along the periocular area has led to the development of new non-surgical therapies. The lower periorbital area is a vital region for facial rejuvenation and several procedures have been studied to treat it, especially procedures with dermal fillers for volume rebuilding. This manuscript aims to describe a filling technique with hyaluronic acid (HA) along the superficial layer of the lower periorbital area, presenting its effectiveness and safety. Our assessment was made by autonomous observers with pictures of before and after treatment, rated from 0 (no enhancement) to 100 (maximum enhancement). Patients’ self-assessment was also performed using a visual analog scale (VAS) based on a 100-mm ruler affording a 0–100 rating. Thirty patients were enrolled in this study. The autonomous observers’ evaluation presented a 78.4 mean improvement rate. Patients’ self-assessments after the treatment were 0% reporting no improvement, 6.7% mild improvement, 23.3% moderate improvement, 66.7% great improvement, and 3.3% maximum improvement. Restylane Vital Skinbooster infiltration at the lower periorbital area proved to be a safe treatment. The described technique is also simple to execute, has a low rate of complications, and produces a high satisfaction rate.
References
Carruthers J, Carruthers A. Social significance of the eyebrows and periorbital complex. J Drugs Dermatol 2014; 13(1 Suppl): s7–s11.
Kane MA. Nonsurgical periorbital and brow rejuvenation. Plast Reconstr Surg 2015; 135(1): 63–71. doi: 10.1097/ PRS.0000000000000831.
Pilkington SJ, Belden S, Miller RA. The tricky tear trough: A review of topical cosmeceuticals for periorbital skin rejuvenation. J Clin Aesthet Dermatol 2015; 8(9): 39–47.
Stutman RL, Codner MA. Tear trough deformity: Review of anatomy and treatment options. Aesthet Surg J 2012; 32(4): 426–440. doi: 10.1177/1090820X12442372.
Huber-Vorländer J, Kürten M. Correction of tear trough deformity with a cohesive polydensified matrix hyaluronic acid: A case series. Clin Cosmet Investig Dermatol 2015; 8: 307–312. doi: 10.2147/CCID.S84117.
Valente DS, Zanella RK, Valente SS. Hyaluronic acid associated with abobotulinumtoxin use along the lower periorbital area: A prospective study. J Clin Exp Dermatol Res 2016; 7(1): 323. doi: 10.4172/2155-9554.1000323.
Cohen JL, Dayan SH, Brandt FS, Nelson DB, Ax-ford-Gatley RA, et al. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg 2013; 39(2): 205–231. doi: 10.1111/dsu.12036.
Raspaldo H, Gassia V, Niforos FR, Michaud T. Global, 3-dimensional approach to natural rejuvenation: Part 1 – Recommendations for volume restoration and the perioc-ular area. J Cosmet Dermatol 2012; 11(4): 279–289. doi: 10.1111/jocd.12003.
Lee S, Yen MT. Injectable hyaluronic acid fillers for pe-riorbital rejuvenation. Int Ophthalmol Clin 2013; 53(3): 1–9. doi: 10.1097/IIO.0b013e31828c0499.
Sharad J. Dermal fillers for the treatment of tear trough deformity: A review of anatomy, treatment techniques, and their outcomes. J Cutan Aesthet Surg 2012; 5(4): 229–238. doi: 10.4103/0974-2077.104910.
Berros P, Lax L, Bétis F. Hyalurostructure treatment: Superior clinical outcome through a new protocol – A 4-year comparative study of two methods for tear trough treatment. Plast Reconstr Surg 2013; 132(6): 924e–931e. doi: 10.1097/PRS.0b013e3182a80683.
Bravo BSF, Rocha CRMD, Bastos JTD, Silva PMC. Comprehensive treatment of periorbital region with hya-luronic acid. J Clin Aesthet Dermatol 2015; 8(6): 30–35.
Landau M, Fagien S. Science of hyaluronic acid beyond filling: Fibroblasts and their response to the extracellular matrix. Plast Reconstr Surg 2015; 136(5 Suppl): 188S– 195S. doi: 10.1097/PRS.0000000000001823.
Valente DS, Zanella RK. Fillers complications for HIV/AIDS lipoatrophy treatment. Rev Bras Cir Plást 2015; 30(2): 335–336. doi: 10.5935/2177-1235.2015RB-CP0160.
Nácul AM, Valente DS. Complications after polymethyl-methacrylate injections. Plast Reconstr Surg 2009; 124(1): 342–343. doi: 10.1097/PRS.0b013e3181a83ac2.
Beleznay K, Carruthers JD, Humphrey S, Jones D. Avoiding and treating blindness from fillers: A review of the world literature. Dermatol Surg 2015; 41(10): 1097–1117. doi: 10.1097/DSS.0000000000000486.
Woodward J, Khan T, Martin J. Facial filler complications. Facial Plast Surg Clin North Am 2015; 23(4): 447–458. doi: 10.1016/j.fsc.2015.07.006.
Ferreira MC. Evaluation of results in aesthetic plastic surgery: Preliminary observations on mammaplasty. Plast Reconstr Surg 2000; 106(7): 1630–1635. doi: 10.1097/ 00006534-200012000-00032.
Wang F, Garza LA, Kang S, Varani J, Orringer JS, et al. In vivo stimulation of de novo collagen production cau-sed by cr¬oss-¬lin¬ked hyaluronic acid dermal filler injections in photo-damaged human skin. Arch Dermatol 2007; 143(2): 155–163. doi: 10.1001/archderm. 143.2.155.
Copyright (c) 2016 Valente DS, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher rights for the first publication with the work concurrently licensed under the Creative Commons Attribution-Noncommercial 4.0 International License
Under this license, author(s) will allow third parties to download, reuse, reprint, modify, distribute and/or copy the content under the condition that the authors are given credit and that the work is not used for commercial purposes. No permission is required from the authors or the publisher.
This broad license intends to facilitate free access, as well as the unrestricted use of original works of all types. This ensures that the published work is freely and openly available in perpetuity.
